|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| G01N 33/50 |
| (11) | Patento numeris | 2771489 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12843416.4 |
| Europos patento paraiškos padavimo data | 2012-10-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-09-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/062240 |
| Data | 2012-10-26 |
| (87) | Numeris | WO 2013/063481 |
| Data | 2013-05-02 |
| (30) | Numeris | Data | Šalis |
| 201161552686 P | 2011-10-28 | US |
| (72) |
BLAKEMORE, Stephen, J., US
LI, Bin, US
MULLIGAN, George, J., US
SCHU, Matthew, C., US
SMITH, Peter, G., US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | BIOMARKERS OF RESPONSE TO NAE INHIBITORS |
| BIOMARKERS OF RESPONSE TO NAE INHIBITORS |